177Lu-SN201

N/A

Report date: 2025/11/26 17:11:08

Base Information

Drug Name177Lu-SN201
Drug Alias NameTumorad177Lu-SN201177Lu-SN-201
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpago Nanomedical Ab
China Registration ClassN/A

Develop Information

Active CompaniesSpago Nanomedical Ab
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A